Should I Buy Sarepta Therapeutics Inc (SRPT)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Sarepta Therapeutics Inc. (SRPT)
Market is closed
News
- First
- << Previous
- 61 - 70
- Next >>
Cathie Wood is Getting Rid of These 10 Stocks
Cathie Wood, the chief of New York-based ARK Investment Management, has become famous on Wall Street in recent years for her aggressive bets on technology stocks.
Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Here's Why Artisan Partners Disposed its Sarepta Therapeutics Inc. (SRPT) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded here.
Is SRPT Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Sarepta Therapeutics (SRPT): Down 50%
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is a commercial-stage biotechnology company engaged in developing unique RNA-targeted therapies and gene therapies for treating rare diseases.
Is SRPT A Good Stock To Buy Now According To Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Sarepta Therapeutics Inc (SRPT): Are Hedge Funds Right About This Stock?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
- First
- << Previous
- 61 - 70
- Next >>
Billionaire Hedge Funds
